IAVI Report
IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. The publication features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.
To access archived issues of IAVI Report dating back to 1996, click here.
Subscribe now to receive IAVI Report right to your inbox.
Questions/comments? Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..
Key Words Search
-
The future of antibody-based HIV prevention
The highly anticipated results from recent HIV prevention trials, and how the field acts on them, may have important implications for future research. This special report identifies the main issues researchers are contemplating in the aftermath of the first trials to test whether a broadly neutralizing antibody could protect people from HIV infection. Read more to find out what 21 leading experts in the field have to say about the future of antibody-based HIV prevention.
- Editor's Letter
-
The race is on
Scientists are applying decades of HIV research experience to the development of SARS-CoV-2 vaccines...
-
Monoclonal antibodies and their potential role in combatting COVID-19
Numerous monoclonal antibodies are already in development for both treatment and prevention. There are many...
-
Finding a global solution for a global problem
An interview with Seth Berkley, chief executive officer of Gavi, the Vaccine Alliance By Kristen Jill...
-
In the midst of a pandemic and preparing for the next
SARS-CoV-2 is the first Disease X. There will certainly be others. Will the world be better...
- Editor's Letter
-
Proven against Ebola, a vector shows its broader potential
Regulatory approval of a vesicular stomatitis virus-based vaccine paves the way for use of this...
-
Turning the tide on TB?
A slew of potential advances in treating and preventing tuberculosis offers new hope in the battle...
-
Vaccines: adapting to the times
Over hundreds of years, researchers have matched contemporary scientific tools to address the...
-
Taking the next step with the mosaic HIV vaccine candidate
Maria Grazia Pau, senior director, compound development team leader for HIV vaccine programs at the...
-
Could vaccines reach remote areas … remotely?
Drone delivery may help overcome the challenge of getting medicines and vaccines to hard-to-reach...
- Editor's Letter
-
‘We’re moving in the right direction’
A conversation with Anatoli Kamali and Penny Moore about the rise of HIV vaccine science in Africa...
-
The best is yet to come
Africa is contributing far more than samples to scientific research. The continent’s scientists are...
-
Stopping HIV where it starts
Marianne Mureithi is part of a team of researchers that just received highly competitive funding...
-
Upcoming efficacy trial illustrates the value of African-led science
We must continue to engage local investigators and develop their capacity to conduct more basic...
- Editor's Letter
-
Is there an HIV prevention crisis?
More HIV-infected people than ever before are receiving life-saving treatment. Despite this...
-
Coding for protection
Although challenges remain, the growing field of mRNA-based vaccine development seems to have a...
-
An industry leader in HIV research
Paul Stoffels of Johnson & Johnson talks about the company’s broad HIV portfolio and the role of...
-
Overflowing with antibodies and optimism
There is more optimism than ever that researchers are on the path to developing vaccines and...
- Editor's Letter
-
Could overly optimistic messages be contributing to the drop in global HIV/AIDS spending?
The pandemic isn’t over, but that might be what donors are hearing. By Mary Rushton A global...
-
A new generation of engineered vaccine candidates enters clinical testing
After decades of work, scientists are now advancing rationally designed vaccine candidates meant...
-
Remembering Adel Mahmoud, a giant in the vaccine world
By Kristen Jill Kresge The vaccine world lost another of its great leaders recently with the...
-
A fast track for vaccine development
Coalition awards US$174 million in grants for research targeting Nipah virus, Lassa fever, and...
-
HIV vaccine efforts herald a new era of vaccinology
By Mark Feinberg, MD, PhD We are at a defining moment in the history of HIV vaccine research. It is...
-
Igniting passion for the long haul
Linda-Gail Bekker talks about how she came to work on HIV and shares her thoughts on an evolving...
- Editor's Letter
-
Applying Innovative Approaches and Technologies to HIV Prevention
Several areas of progress in using antibodies for HIV prevention were showcased at the recent...
-
A Mean Flu Season Swings a Spotlight on Vaccines
Influenza, like HIV, is a highly variable menace. A particularly bad flu season has researchers...
-
Drawing Lessons from AIDS to Prevent Future Epidemics
Jonathan Quick describes how the right mix of science, funding, leadership, and communication can come...
-
Remembering David Cooper: A Great Leader in HIV Epidemiology, Treatment, and Prevention
The battle against HIV/AIDS lost another great soldier recently with the passing of Australian...
-
"She was the best of us"
Remembering Bonnie Mathieson: A champion of young scientists At the Annual Scientific Retreat in...
